Market Overview:
The global medical biomimetics market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biomimetic products in the medical field, technological advancements, and rising funding for research and development in the field of biomimetics. Based on type, the cardiovascular segment is expected to account for the largest share of the global medical biomimetics market in 2018. This segment is projected to grow at a CAGR of 11.1% from 2018 to 2030 due to increasing incidences of cardiovascular diseases across the globe.
Product Definition:
Medical biomimetics is the application of principles gleaned from nature to solving problems in medicine. The use of medical biomimetics can be as varied as copying the structure of a seashell to create a new type of artificial joint, or using the slime produced by certain bacteria to coat medical devices and help prevent infection.
The importance of medical biomimetics lies in its ability to provide novel solutions to difficult problems. By looking at how nature has solved similar issues, scientists can often develop new technologies and treatments that are more effective and less invasive than traditional methods. Additionally, many times natural solutions are more environmentally friendly and sustainable than those developed through traditional engineering techniques.
Cardiovascular:
Cardiovascular systems are the biological machines that enable the transport of blood through arteries and veins with the help of heart valves. Cardiovascular diseases (CVDs) include coronary heart disease, stroke, hypertension, and peripheral vascular disease.
Orthopedic(Prostheses, Exoskeleton):
Orthopedic prostheses are used to restore body parts and provide comfort to patients. They comprise of a wide range of devices such as artificial hands, feet, arms, legs and upper extremities. Orthopedic prostheses have gained significant traction in the medical robotics market owing to their ability to improve mobility in amputees. This is achieved by providing balance and stability while walking or running using knee joints for example.
Application Insights:
The wound healing segment dominated the global medical biomimetics market in terms of revenue share in 2017. The high share is attributable to the rising prevalence of chronic wounds and the increasing number of surgeries. According to a study published by NCBI, it was estimated that around 60% of patients visiting primary healthcare clinics have some type of wound. Moreover, as per another study published by National Center for Biotechnology Information (NCBI), around 1-2%of total population will experience a severe cutaneous injury every year due to various reasons such as road accidents, falls etc. This indicates a huge potential market for product manufacturers over the forecast period.
Tissue engineering is anticipated to be one of the fastest growing segments during the forecast period owing to increasing demand for replacement organs.
Regional Analysis:
North America dominated the global market in 2017. This is attributed to the presence of a large number of companies, research centers and universities involved in biomimetic research. The region is expected to maintain its dominance over the forecast period as well owing to factors such as favorable government policies and increasing R&D expenditure by pharmaceutical companies for drug delivery systems using stem cells or 3D-bioprinting technology.
Asia Pacific regional market captured significant share in 2017 due to rising healthcare spending by developing countries such as China, India, Singapore & South Korea along with Japan.
Europe was estimated at USD X million in 2017.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global medical biomimetics market is expected to grow at a CAGR of over 9% during the forecast period. This can be attributed to the increasing demand for minimally invasive surgeries, which are less traumatic and cause less pain and scarring than traditional surgery. Biomimetic materials are used in various medical devices such as stents, catheters, and implants that help reduce surgical trauma.
- Growing prevalence of chronic diseases: The global medical biomimetics market is also driven by the growing prevalence of chronic diseases such as cancer, heart disease, and diabetes. Biomimetic materials are used in various diagnostic tests and treatments for these diseases. For instance, biomaterials are being increasingly used in cancer diagnosis and treatment due to their ability to interact with cells selectively.
- Rising R&D expenditure by pharmaceutical companies: Pharmaceutical companies are investing heavily in R&D to develop new drugs that use biomimetic materials as active ingredients or delivery vehicles thereof .This is expected to drive the growth of the global medical biomimetics market during the forecast period .Some notable examples include Novartis’s drug candidate LCZ696 (a novel dual angiotensin receptor blocker/neurokinin A receptor antagonist) which uses a peptide derived from spider venom as an active ingredient; Eli Lilly’s drug candidate solanezumab (an anti-amyloid
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Biomimetics Market Research Report
By Type
Cardiovascular, Orthopedic(Prostheses, Exoskeleton), Ophthalmology, Dental
By Application
Wound Healing, Tissue Engineering, Drug Delivery
By Companies
Avinent, Hstar Technologies Corporation, Applied Biomimetic A/S, Veryan Medical, BioHorizons IPH, Biomimetics Technologies, BioTomo, SynTouch LLC, Forschungszentrum Jülich GmbH, Küstenforschung GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
163
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Medical Biomimetics Market Report Segments:
The global Medical Biomimetics market is segmented on the basis of:
Types
Cardiovascular, Orthopedic(Prostheses, Exoskeleton), Ophthalmology, Dental
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Wound Healing, Tissue Engineering, Drug Delivery
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Avinent
- Hstar Technologies Corporation
- Applied Biomimetic A/S
- Veryan Medical
- BioHorizons IPH
- Biomimetics Technologies
- BioTomo
- SynTouch LLC
- Forschungszentrum Jülich GmbH
- Küstenforschung GmbH
Highlights of The Medical Biomimetics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cardiovascular
- Orthopedic(Prostheses, Exoskeleton)
- Ophthalmology
- Dental
- By Application:
- Wound Healing
- Tissue Engineering
- Drug Delivery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Biomimetics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical biomimetics is the application of principles from biology to medical devices and treatments. This includes using natural materials and processes to create new medical technologies, as well as studying how biological systems work in order to improve existing medical technologies. Medical biomimetics can help improve the efficiency, effectiveness, and safety of treatments by mimicking natural processes or structures.
Some of the key players operating in the medical biomimetics market are Avinent, Hstar Technologies Corporation, Applied Biomimetic A/S, Veryan Medical, BioHorizons IPH, Biomimetics Technologies, BioTomo, SynTouch LLC, Forschungszentrum J¼lich GmbH, K¼stenforschung GmbH.
The medical biomimetics market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Biomimetics Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Medical Biomimetics Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Medical Biomimetics Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Medical Biomimetics Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Medical Biomimetics Market Size & Forecast, 2018-2028 4.5.1 Medical Biomimetics Market Size and Y-o-Y Growth 4.5.2 Medical Biomimetics Market Absolute $ Opportunity
Chapter 5 Global Medical Biomimetics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Medical Biomimetics Market Size Forecast by Type
5.2.1 Cardiovascular
5.2.2 Orthopedic(Prostheses
5.2.3 Exoskeleton)
5.2.4 Ophthalmology
5.2.5 Dental
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Medical Biomimetics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Medical Biomimetics Market Size Forecast by Applications
6.2.1 Wound Healing
6.2.2 Tissue Engineering
6.2.3 Drug Delivery
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Biomimetics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Biomimetics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Medical Biomimetics Analysis and Forecast
9.1 Introduction
9.2 North America Medical Biomimetics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Medical Biomimetics Market Size Forecast by Type
9.6.1 Cardiovascular
9.6.2 Orthopedic(Prostheses
9.6.3 Exoskeleton)
9.6.4 Ophthalmology
9.6.5 Dental
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Medical Biomimetics Market Size Forecast by Applications
9.10.1 Wound Healing
9.10.2 Tissue Engineering
9.10.3 Drug Delivery
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Medical Biomimetics Analysis and Forecast
10.1 Introduction
10.2 Europe Medical Biomimetics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Medical Biomimetics Market Size Forecast by Type
10.6.1 Cardiovascular
10.6.2 Orthopedic(Prostheses
10.6.3 Exoskeleton)
10.6.4 Ophthalmology
10.6.5 Dental
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Medical Biomimetics Market Size Forecast by Applications
10.10.1 Wound Healing
10.10.2 Tissue Engineering
10.10.3 Drug Delivery
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Medical Biomimetics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Medical Biomimetics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Medical Biomimetics Market Size Forecast by Type
11.6.1 Cardiovascular
11.6.2 Orthopedic(Prostheses
11.6.3 Exoskeleton)
11.6.4 Ophthalmology
11.6.5 Dental
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Medical Biomimetics Market Size Forecast by Applications
11.10.1 Wound Healing
11.10.2 Tissue Engineering
11.10.3 Drug Delivery
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Medical Biomimetics Analysis and Forecast
12.1 Introduction
12.2 Latin America Medical Biomimetics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Medical Biomimetics Market Size Forecast by Type
12.6.1 Cardiovascular
12.6.2 Orthopedic(Prostheses
12.6.3 Exoskeleton)
12.6.4 Ophthalmology
12.6.5 Dental
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Medical Biomimetics Market Size Forecast by Applications
12.10.1 Wound Healing
12.10.2 Tissue Engineering
12.10.3 Drug Delivery
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Medical Biomimetics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Medical Biomimetics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Medical Biomimetics Market Size Forecast by Type
13.6.1 Cardiovascular
13.6.2 Orthopedic(Prostheses
13.6.3 Exoskeleton)
13.6.4 Ophthalmology
13.6.5 Dental
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Medical Biomimetics Market Size Forecast by Applications
13.10.1 Wound Healing
13.10.2 Tissue Engineering
13.10.3 Drug Delivery
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Biomimetics Market: Competitive Dashboard
14.2 Global Medical Biomimetics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Avinent
14.3.2 Hstar Technologies Corporation
14.3.3 Applied Biomimetic A/S
14.3.4 Veryan Medical
14.3.5 BioHorizons IPH
14.3.6 Biomimetics Technologies
14.3.7 BioTomo
14.3.8 SynTouch LLC
14.3.9 Forschungszentrum Jülich GmbH
14.3.10 Küstenforschung GmbH